Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
Authors
Keywords
Andrographolide, RANKL, Osteoclast, Breast cancer, Bone metastasis
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 144, Issue 1, Pages 33-45
Publisher
Springer Nature
Online
2014-01-30
DOI
10.1007/s10549-014-2844-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocimum gratissimumretards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases
- (2013) Pratima Nangia-Makker et al. CANCER BIOLOGY & THERAPY
- Anti-Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3 and NF- B Activation
- (2013) C.-L. Chen et al. JOURNAL OF IMMUNOLOGY
- Progress in the treatment of bone metastases in cancer patients
- (2012) Malgorzata Mackiewicz-Wysocka et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Denosumab for the Treatment of Bone Metastases in Patients with Advanced Cancer
- (2012) T. Kurata et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption
- (2012) An Qin et al. PLoS One
- Management of bone metastases in refractory prostate cancer – role of denosumab
- (2012) Channing Paller et al. Clinical Interventions in Aging
- Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors
- (2012) Allan Lipton et al. Expert Review of Clinical Pharmacology
- Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation
- (2011) L.-J. Wang et al. JOURNAL OF DENTAL RESEARCH
- Inhibition of TNF-α-Induced Inflammation by Andrographolide via Down-Regulation of the PI3K/Akt Signaling Pathway
- (2011) Haw-Wen Chen et al. JOURNAL OF NATURAL PRODUCTS
- Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis
- (2010) Jude Canon et al. BONE
- Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK
- (2010) Estabelle Ang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Crosstalk between p53 and nuclear factor-κB systems: pro- and anti-apoptotic functions of NF-κB
- (2009) K. Puszynski et al. IET Systems Biology
- Potency of Andrographolide as an Antitumor Compound in BHC-Induced Liver Damage
- (2009) Neha P. Trivedi et al. INTEGRATIVE CANCER THERAPIES
- Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor- B Signal
- (2009) J.-H. Lee et al. MOLECULAR PHARMACOLOGY
- Effect of bisphosphonates on pain and quality of life in patients with bone metastases
- (2009) Luis Costa et al. Nature clinical practice. Oncology
- NF-κB functions in osteoclasts
- (2008) N.S. Soysa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare
- (2008) Artur Gevorgyan et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Synthesis and evaluation of antibacterial activities of andrographolide analogues
- (2008) Xiaojian Jiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- RANK ligand as a therapeutic target for bone metastases and multiple myeloma
- (2007) G. David Roodman et al. CANCER TREATMENT REVIEWS
- Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads
- (2007) Arvind S. Negi et al. MEDICINAL RESEARCH REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started